ALFA Finder| Revenue growth | Consolidated revenue +8% YoY in Q2, +11% in H1; volume-driven. |
|---|---|
| Margins | Consolidated EBITDA fell to ₹381 Cr from ₹537 Cr; margins contracted. |
| Order book | Acquired Searles Valley contracts, about 0.5 mt over two years. |
| Demand visibility | India demand healthy; global soda ash oversupplied; pricing range-bound. |
| Management confidence | Defensive on Kenya and stake sale; upbeat 'confident' tone despite losses. |
Growth
Consolidated revenue +8% to ₹4,177 Cr on volumes; standalone EBITDA +22% but PAT -31%. Growth is volume-led and margins compressed.
Outlook
No quantified guidance; pricing expected range-bound. Capex about ₹1,000 Cr incl. growth; net debt ₹6,127 Cr excluding leases.
Risks
Kenya operations suspended with unresolved legal path; China oversupply, 1.89 mt producer inventory; UK energy spike; weak US export realizations.
Last quarter's promises, checked
Delivered
- Capex ~₹1,200 Cr (≈FY26 depreciation, stay below) → ~₹1,000 Cr incl. growth (= BEAT)
Partly delivered
- Non-core land monetisation after Q2 → ₹796 Cr investment sale, land not cited (= PARTIAL)
Missed
- UK EBITDA-positive from next quarter → UK gas costs cut consolidated EBITDA; UK figure not disclosed (= MISS)
- Kenya HFO hedged to Oct, margin to adjust as spot falls → Kenya suspended, legal path unresolved (= MISS)
Earnings Call Transcript filed with NSE, NSE: TATACHEM. Summary written with AI assistance from the document.
Tata Chemicals Ltd: key numbers
- Share price
- ₹607.45
- Market cap
- ₹15,475 Cr
- Revenue (annual)
- ₹14,584 Cr
- Net profit (annual)
- ₹-1,896 Cr
- P/E (TTM)
- -7.2×Sector 28.2×
- Promoter holding
- 37.98%+0.00% QoQ
- FII holding
- 11.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Chemicals Ltd
All →Tata Chemicals Results Update
Tata Chemicals' Q2FY27 standalone revenue rose 8% to ₹1,303 Cr, with EBITDA up 22%. Consolidated results show a ₹50 Cr loss after tax amid soda ash pricing pressure.
Tata Chemicals Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹4,177 Cr (+8% YoY), EBITDA ₹381 Cr (-29%), PAT loss ₹(50) Cr. H1 revenue ₹8,432 Cr (+11%). Strategy: pivot toward stable, application-led LIFE businesses.
Tata Chemicals Q2 FY27 Results: Net Loss of ₹50 Cr
Tata Chemicals Ltd reported revenue from operations of ₹4,177 Cr (+7.7% YoY) and a net loss of ₹50 Cr for Q2 FY27.
- Key figure
- Net loss ₹50 Cr
Tata Chemicals Other Announcement
Tata Chemicals disclosed an ESG score of 68.74 from Niche Ninety Nine, an unengaged provider. The score uses public FY2025-26 data; no operational impact.
Tata Chemicals Board Meeting Date
Tata Chemicals will hold a board meeting on 7 November 2026 to approve half-year results. Trading window stays closed until 48 hours after publication.
Tata Chemicals Legal & Regulatory
Tata Chemicals provided a Regulation 30 update on its Kenyan subsidiary TCML. The Kenyan High Court ruled it lacks jurisdiction over the dispute with the Mining Ministry, which is now under government technical review.